Elecsys Vitamin D total II 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Roche Diagnostics International Ltd 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2018-04-25
  • 사례 출판 날짜
    2018-04-25
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: roche diagnostics elecsys vitamin d total ii medical device manufacturer, roche diagnostics international ltd, has issued a medical device safety alert concerning its elecsys vitamin d total ii [product description (catalog number): a) elecsys vitamin d total ii - 100 tests (07464215190); b) elecsys vitamin d total ii - 300 tests (07028148190)]. the manufacturer has received a number of reports of performance issues (i.E. non-reproducible, false high results) during the implementation of the elecsys vitamin d total ii assay on modular analytics e 170, cobas e 601 and cobas e 602 systems. the observations were made in duplicate measurements during assay validation of elecsys vitamin d total ii or in method comparisons with elecsys vitamin d total, where the falsely-elevated discrepant value did not fit the expected result. when repeated, the elevated results were not confirmed in reruns. the issue manifests as follows: the first result is elevated, either above the upper end of the measuring range (>100 ng/ml or >250 nmol/ml) or within the measuring range; and repeats are significantly lower. according to the manufacturer, the issues have been seen on modular analytics e 170, cobas e 601 and cobas e 602 systems with an occurrence of between 1/100,000 and 1/1,000,000 tests sold. rare cases have been reported on cobas e 411 and cobas e 801. the manufacturer temporarily blocked the distribution of the affected product assay on modular analytics e 170, cobas e 601 and cobas e 602 systems. it is carrying out further investigations to understand the underlying root cause and conditions under which this issue arises the affected users are advised to do the following actions prior to measurements with elecsys vitamin d total ii on all analyzers: do a thorough inspection of your pre-analytical handling for a correct assay performance of elecsys vitamin d total ii and to comply to the individual specifications of the primary tube manufacturers for all tubes in use (in particular the centrifugation conditions are important and the elimination of foam). if the issue persists, switch from plasma to serum. if they still encounter the issue on plasma or serum, do a re-centrifugation in a secondary tube for 10 min at 2000 x g prior to measurement with elecsys vitamin d total ii. if the above suggestions did not improve the issue, the users should consider switching to vitamin d total (06506780160) or elecsys vitamin d total (05894913190) and contact the manufacturer. according to the local supplier, the affected product is distributed in hong kong. if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 25 april 2018.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: Roche Diagnostics Elecsys Vitamin D total II
  • Manufacturer

Manufacturer